Reported Jan 11, 2017 · Terminated

Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells…

Wells Pharmacy Network LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Wells Pharmacy Network LLC · 1210 SW 33rd Ave · Ocala, FL · 34474-2853

Is this the product you have?

  • Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
Lot codes and dates

3 of 3 products

Products covered by this recall
#Product as published
1lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known
2lot code: 04072016@10, 05102016@18, 06232016@12, 08182016@26 b) Known
3lot code: 04122016@19, 05042016@18, 06142016@43, 07122016@40, 07262016@47.
Amount recalled
a) 257 vials and b) 460 vials

This recall covers 97 products

The agency filed one notice per product. You are reading one of them; the other 96 are below.

84 more are in the archive.

Where it was sold

  • Nationwide

Why it was recalled

Lack of Assurance of Sterility

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Wells Pharmacy Network LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jul 2, 2021 · Data as of Sep 19, 7:15 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.